Cellectar Biosciences, Inc. — Director's Dealing 2017

Apr 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2017-04-18

Reporting Person: Kolean Chad J (VP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-18	Common stock	A	80000	$0.00	Acquired	80000	Direct

Footnotes

F1: Common stock grant that vests in equal annual increments on March 2, 2018, March 2, 2019, and March 2, 2020.